Behind declines for shares of Amgen and Merck, the Dow Jones Industrial Average is falling Monday morning. Supported by world-class markets data from Dow Jones and FactSet, and partnering with ...

Merck delivered a strong Q4 double beat, with robust pipeline momentum and a healthy new launch cycle. Read more on the ...

Merck (NYSE:MRK) received Health Canada approval for ENFLONSIA, its RSV preventive therapy for infants. The authorization ...

O 4, Scotiabank raised its price target on Merck & Co., Inc. (NYSE:MRK) to $136 from $120 and maintained an Outperform rating ...

Eikon was founded ​in 2019 by Chemistry Nobel Prize winner Eric Betzig, along with Xavier Darzacq, Luke Lavis and Robert ...

Bristol Myers Squibb on Thursday delivered strong fourth quarter results — and better yet, issued a 2026 forecast that was ...

Merck reported revenue for the fourth quarter was $16.4 billion, an increase of 5% over the fourth quarter of 2024. For the ...

For full-year 2025, Merck reported worldwide sales of $65B, up 1% Y/Y, or 2% excluding FX, while adjusted EPS totaled $8.98.

Merck & Co. reports Q4 2025 earnings on Tuesday, Feb. 3, 2026, before market open. Wall Street expects earnings of $2.01 per ...

Merck & Co shares are trading up 1.19% at $107.25 at the time of this writing on Thursday morning. About Merck & Co. Merck makes pharmaceutical products to treat several condition ...

It was revealed in a recent SEC filing that Chirfi Guindo, Chief Marketing Officer at Merck & Co (NYSE: MRK) made a ...

Amazon's big report is due Thursday The online retail giant will release numbers Thursday afternoon. The results will be ...